These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 33501448)

  • 1. DINC-COVID: A webserver for ensemble docking with flexible SARS-CoV-2 proteins.
    Hall-Swan S; Antunes DA; Devaurs D; Rigo MM; Kavraki LE; Zanatta G
    bioRxiv; 2021 Jan; ():. PubMed ID: 33501448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DINC-COVID: A webserver for ensemble docking with flexible SARS-CoV-2 proteins.
    Hall-Swan S; Devaurs D; Rigo MM; Antunes DA; Kavraki LE; Zanatta G
    Comput Biol Med; 2021 Dec; 139():104943. PubMed ID: 34717233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DINC 2.0: A New Protein-Peptide Docking Webserver Using an Incremental Approach.
    Antunes DA; Moll M; Devaurs D; Jackson KR; Lizée G; Kavraki LE
    Cancer Res; 2017 Nov; 77(21):e55-e57. PubMed ID: 29092940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DINC: a new AutoDock-based protocol for docking large ligands.
    Dhanik A; McMurray JS; Kavraki LE
    BMC Struct Biol; 2013; 13 Suppl 1(Suppl 1):S11. PubMed ID: 24564952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking.
    Castillo-Campos L; Velázquez-Libera JL; Caballero J
    Front Mol Biosci; 2023; 10():1215499. PubMed ID: 37426421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some
    Amin SA; Ghosh K; Gayen S; Jha T
    J Biomol Struct Dyn; 2021 Aug; 39(13):4764-4773. PubMed ID: 32568618
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Huynh T; Cornell W; Luan B
    Front Chem; 2020; 8():624163. PubMed ID: 33614597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
    Balkrishna A; Mittal R; Arya V
    Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening.
    Zhang LC; Zhao HL; Liu J; He L; Yu RL; Kang CM
    Future Med Chem; 2022 Mar; 14(6):393-405. PubMed ID: 35220726
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases.
    Sivakumar D; Stein M
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34071582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
    Amin SA; Banerjee S; Ghosh K; Gayen S; Jha T
    Bioorg Med Chem; 2021 Jan; 29():115860. PubMed ID: 33191083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19.
    Rehman MT; AlAjmi MF; Hussain A
    Curr Pharm Des; 2021; 27(33):3577-3589. PubMed ID: 33200697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working goal of Brazilein sappan wood as a candidate for SARS-coV-2 antivirus drug against spike (S) glycoprotein, papain-like proteinase, and main protease:
    Kurniawan E; Krihariyani D
    J Adv Pharm Technol Res; 2021; 12(3):298-304. PubMed ID: 34345611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of polyphenols from
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease.
    Bosken YK; Cholko T; Lou YC; Wu KP; Chang CA
    Front Mol Biosci; 2020; 7():174. PubMed ID: 32850963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2.
    Johnson TO; Adegboyega AE; Iwaloye O; Eseola OA; Plass W; Afolabi B; Rotimi D; Ahmed EI; Albrakati A; Batiha GE; Adeyemi OS
    J Pharmacol Sci; 2021 Sep; 147(1):62-71. PubMed ID: 34294374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
    Huang SY; Zou X
    Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.
    Huynh T; Wang H; Luan B
    Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19.
    Bhati S
    Heliyon; 2020 Nov; 6(11):e05558. PubMed ID: 33251371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.